鬼吹灯之牧野诡事

Pfizer cuts full-year outlook due to declining sales of Covid-19-related products_我的网站

A |     中新社北京8月26日电 (记者 黄钰钦)8月25日，由中共中央对外联络部和美国亚洲协会共同主办的第三届中美1.5轨对话在北京举行。    Shares of Pfizer are in retreat on the first day of trading after the drug company said sales of its COVID-19 vaccine and its coronavirus treatment are weaker than it had expected and cut revenue projections by $9 billion for the year. Falling sales of both clipped sales in the second quarter, but Pfizer said in August that it expected a rebound in the second half of 2023. Shares of Pfizer slipped more than 1% before the opening bell Monday and Moderna, which is heavily reliant on the competing vaccine it makes, slid nearly 5%. Pfizer said Friday that global usage of Paxlovid is trending slightly above last year, but that it's still below expectations.The fall vaccination period just began and the New York City drugmaker said that it's too soon to get a handle on vaccination rates for the year.Full-year revenue for Paxlovid and Comirnaty is expected to be approximately $12.5 billion, short $9 billion of what it had expected. Pfizer is lowering its full-year revenue expectations for Paxlovid by approximately $7 billion. That number also accounts for delayed commercialization of the product, which was pushed to January 2024 from the company's previous expectation of commercialization in the second half of this year. Pfizer is also lowering its 2023 revenue expectations for Comirnaty by approximately $2 billion due to lower-than-expected vaccination rates.Pfizer Inc. now foresees 2023 revenue in a range of $58 billion to $61 billion, down from its prior forecast for $67 billion to $70 billion. It now projects full-year adjusted earnings between $1.45 and $1.65 per share due to lower-than-anticipated revenue for COVID-19-related products and inventory write-offs.That is short of the full-year revenue of $63.61 billion and earnings of $2.77 per share that Wall Street was expecting, and far short of the company's previous projections of per-share earning between $3.25 and $3.45. JPMorgan said the company's update solves an ongoing U.S. Paxlovid inventory debate and it anticipates the company's bigger-than-expected cuts to its sales projections will help put a floor under per-share earnings expectations for next year.。来自中方有关部门、地方政府、智库、高校以及美国亚洲协会等方面的约40名代表，围绕“建设性战略稳定——新时代中美务实合作”进行交流。                        　　所谓一轨，通常指国家政府之间的正式外交沟通，由现任政府官员代表国家进行谈判和磋商，有明确的官方属性。二轨则更多是非官方交流，参与者多是智库学者、前政要、企业人士等，不代表政府进行正式谈判，但能够在相对宽松的环境中交换观点，为政策制定提供参考。         　　两者之间的1.5轨，是介于官方正式外交和民间对话之间的沟通，参与者既包括政府部门等方面人士，也包括智库、学界、工商界等人士。

B |          　　“1.5轨最大的特点，是在官方和民间之间搭起一座特殊桥梁。

C | ”中国人民大学全球治理与发展研究院高级研究员苏浩指出，它既能够接触政策层面的现实问题，又能保留较灵活的讨论空间。

D |          　　这种机制并非中美间独有。早在2015年，中韩双方就举行了第一次1.5轨对话，旨在加强两国政府和二轨对话间的对接。

E |          　　中美1.5轨对话，同样与中美关系需要保持沟通的大背景密切相关。

F | 2023年，首届中美1.5轨对话以视频方式举行。2024年，第二届对话在北京举行，讨论议题进一步延伸至经贸、气候变化、卫生、人工智能、人文交流等领域。

G |          　　从三届对话来看，这一机制的功能不断拓展。

H | 本届对话共设置增进中美政治互信，拓展中美经贸合作，探索中美人工智能与科技、国际地区事务合作，促进中美医疗合作与人文交流等四个议题。         　　“这说明1.5轨对话正在从‘保持沟通’走向‘寻找合作’。

I | ”苏浩说，三届对话最重要的成果，未必是形成多少具体文件，而是逐步形成可以持续运转的沟通平台，让双方不同领域人士保持接触，把现实问题和合作设想带到桌面上讨论。         　　中美关系正处于重要节点。今年5月中美元首历史性会晤确立了中美建设性战略稳定关系的新定位，为未来3年乃至更长时间的中美关系作出战略指引。         　　“中美关系越是复杂，越需要保持多层次、多领域沟通。”苏浩认为，“1.5轨能够做的，就是把分歧讲清楚，把可以合作的事情找出来，通过持续交流减少误判。”          　　一个稳定的中美关系需要元首外交引领，也需要政府部门间的专业沟通，还需要智库、企业、学界等社会各界保持接触。三届中美1.5轨对话的举行，正是这种多层次的体现，为中美管控分歧、增进理解、寻找合作创造更多可能。(完) 【编辑:曹子健】。

J |

Current article:http://w87zl6.qiuergejiaolaiaozhuangshi.buzz/news/20260826_14126.html

Published on:11:56:44